2010
DOI: 10.1039/c0an00265h
|View full text |Cite
|
Sign up to set email alerts
|

Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer

Abstract: Serum samples from kidney cancer patients and healthy controls were analyzed by both direct infusion mass spectrometry (DIMS) and liquid chromatography-mass spectrometry (LC-MS) with a high resolution ESI-Q-TOFMS. The classification and biomarker discovery capacities of the two methods were compared, and MS/MS experiments were carried out to identify potential biomarkers. DIMS had comparable classification and prediction capabilities to LC-MS but consumed only ~5% of the analysis time. With regard to biomarker… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
89
1
4

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 139 publications
(95 citation statements)
references
References 51 publications
1
89
1
4
Order By: Relevance
“…According to the study of Lin et al, direct-infusion MS saves time, requiring only 5% of the analysis time of LC-MS. However, LC-MS is capable of finding twice as many differential metabolites as direct-infusion MS [17].…”
Section: Methodsmentioning
confidence: 99%
“…According to the study of Lin et al, direct-infusion MS saves time, requiring only 5% of the analysis time of LC-MS. However, LC-MS is capable of finding twice as many differential metabolites as direct-infusion MS [17].…”
Section: Methodsmentioning
confidence: 99%
“…DIMS provides a high-throughput system for metabolic profiling because a large number (hundreds or thousands) of samples can be analyzed in a given period of time. The use of DIMS for the large sample sets probably reflects the difficulty in maintaining reproducibility of the LC-MS technique over many weeks or months, where chromatographic drift or small changes in instrument performance can impair the data analysis (Barrett, 2012;Lin et al, 2010).…”
Section: Human Blood Metabolomementioning
confidence: 99%
“…When large-scale multi-batch experiments are designed, robust workflows have to be developed to minimize experiment analytical variation [25]. Lin et al compared the classification and biomarker discovery capacities of direct infusion ESI-MS and liquid chromatography (LC)-MS [26]. For that purpose, serum samples from kidney cancer patients and healthy controls were analyzed by both analytical techniques.…”
Section: Direct Infusion Msmentioning
confidence: 99%